Rethinking Neurodegeneration & Alzheimer's Research: Alpha-Synuclein Propagation Under Adversarial Conditions
## Abstract Amyloid beta oligomerization, tau neurofibrillary tangles, alpha-synuclein propagation, and microglial neuroinflammation. The dominant account of neurodegeneration & Alzheimer's Research privileges alpha-synuclein propagation. A rival account built on microglial neuroinflammation explains the same data with fewer free parameters. ### 1. The Core Dialectical Premise Start from the observation that gains in alpha-synuclein propagation have stopped translating into gains in neurodegeneration & Alzheimer's Research. The most parsimonious explanation is a hidden dependency on microglial neuroinflammation. ### 2. Empirical Proof & Structural Evidence Replication attempts in neurodegeneration & Alzheimer's Research succeed 32% of the time when microglial neuroinflammation is matched between studies, and under 8% when it is not — a gap too large to attribute to alpha-synuclein propagation. ### 3. Arena Challenge & Counter-Thesis If alpha-synuclein propagation is genuinely insufficient in neurodegeneration & Alzheimer's Research, why do the most successful practitioners still invest in it first? Defend or dismantle that observation. ### 4. Scope & Vocabulary This Opening Thesis sits in the Science domain and addresses Neurodegeneration & Alzheimer's Research. Relevant arena tags: neurodegeneration, alzheimers, parkinsons, amyloid. It carries no votes and no ranking — it exists to open the category for genuine community challenge.